Compass Therapeutics CMPX Balance Sheet (2018-2026)

NASDAQ CMPX
$2.40 +0.03 (+1.27%)
As of: Sep 4, 2026 · 12:48 PM EDT
Reported Financials

Compass Therapeutics Quarterly Balance Sheet

Periods 33 quarters
Latest Jun 2026

Compass Therapeutics reported total assets of $190.17M and total liabilities of $24.12M for the quarter ended Jun 2026, up 63.0% year over year. This balance sheet covers 33 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
4.90M5.03M5.18M5.17M5.37M5.57M5.76M5.94M6.11M6.27M6.42M6.57M6.72M6.36M6.64M6.60M6.62M6.64M6.65M6.59M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
25.51M144.51M136.40M26.24M16.48M34.95M27.03M19.28M30.43M24.23M43.48M19.40M37.37M44.05M41.62M23.42M46.78M31.21M55.74M36.02M
Prepaid Assets
3.06M2.59M3.90M2.53M1.95M8.18M8.43M6.52M2.88M1.42M2.36M7.32M5.74M6.03M11.51M5.25M1.23M0.91M1.00M1.01M
Current Assets
28.57M147.10M140.28M134.54M122.55M194.79M183.60M175.27M166.58M153.88M158.61M153.55M141.14M132.75M124.14M106.19M221.12M209.82M195.69M180.89M
Non-Current Assets
Property, Plant & Equipment (Net)
1.44M2.24M2.14M1.85M1.71M1.57M1.37M1.20M1.05M0.90M0.74M0.59M0.49M0.35M0.10M0.13M0.12M0.10M0.17M0.32M
Other Non-Current Assets
0.32M0.32M0.32M0.32M0.32M0.32M0.32M0.32M0.32M0.32M0.32M0.32M0.57M0.57M0.57M0.57M0.57M0.57M0.57M0.57M
Non-Current Assets
6.33M6.65M6.28M5.71M5.28M4.85M4.37M3.91M3.45M2.99M2.53M2.06M8.01M7.65M7.31M10.50M10.14M9.77M9.48M9.28M
Assets
34.90M153.76M146.56M140.26M127.84M199.65M187.97M179.18M170.04M156.88M161.14M155.61M149.15M140.40M131.45M116.70M231.26M219.59M205.17M190.17M
Liabilities
Current Liabilities
Accounts Payables
0.87M0.87M0.26M6.53M2.76M3.38M1.12M0.72M2.31M4.09M0.85M1.19M0.96M2.25M1.58M2.60M3.10M1.58M0.91M2.91M
Notes Payables
Payables
0.87M0.87M0.26M6.53M2.76M3.38M1.12M0.72M2.31M4.09M0.85M1.19M0.96M2.25M1.58M2.60M3.10M1.58M0.91M2.91M
Accumulated Expenses
2.00M8.78M8.05M3.30M5.74M11.69M8.94M7.83M5.64M2.51M1.81M7.23M2.92M6.29M13.21M10.99M8.68M11.38M8.00M11.59M
Other Accumulated Expenses
0.73M0.47M1.47M0.29M0.09M0.10M0.14M0.26M0.39M0.24M0.28M0.31M0.17M0.62M0.27M0.38M0.14M0.48M0.71M1.18M
Short term Debt
3.74M
Current Leases
1.07M0.99M1.03M1.05M1.07M1.10M1.12M1.15M1.17M1.20M1.22M1.09M0.56M0.34M0.11M0.27M1.00M1.00M1.37M1.64M
Current Taxes
Total Current Liabilities
7.68M10.63M9.33M10.88M9.58M16.17M11.19M9.70M9.12M7.80M3.89M9.51M4.43M8.87M14.90M13.86M12.41M13.97M10.28M16.13M
Non-Current Liabilities
Non-Current Debt
Preferred Stock Liabilities
Operating Leases
3.33M3.05M2.74M3.50M3.22M1.84M2.64M2.34M2.04M0.54M1.41M1.09M6.88M6.30M6.38M9.90M9.83M8.83M9.79M9.63M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
11.01M13.68M12.07M13.33M11.72M18.01M12.71M10.89M9.99M8.34M4.08M9.51M10.75M15.17M21.17M23.49M21.65M22.80M18.70M24.12M
Shareholder's Equity
Total Debt
3.74M
Common Equity
23.89M140.08M134.49M126.93M116.12M181.64M175.26M168.29M160.04M148.54M157.06M146.10M138.40M125.23M110.28M93.21M209.61M196.79M186.47M166.05M
Liabilities and Shareholders Equity
34.90M153.76M146.56M140.26M127.84M199.65M187.97M179.18M170.04M156.88M161.14M155.61M149.15M140.40M131.45M116.70M231.26M219.59M205.17M190.17M
Retained Earnings
-220.61M-233.59M-240.75M-249.25M-261.22M-272.81M-280.65M-291.93M-301.89M-315.31M-326.10M-339.17M-349.65M-364.68M-381.32M-401.20M-415.46M-431.17M-449.49M-474.64M
Preferred Shares
Treasury Shares